The purpose of this study is to identify the long-term safety of TZIELD in Stage 2 T1D patients treated with TZIELD under real-world conditions. A comparison group of patients with Stage 2 T1D who were not treated with TZIELD will also be enrolled.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Nina Jain
Pediatrics - Endocrinology
Clinical or Medical
Observational
Diabetes
24-1359
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
